Promoter methylation-regulated miR-148a-3p inhibits lung adenocarcinoma (LUAD) progression by targeting MAP3K9

Lu Liang(ON Semiconductor (United States)), Xiyong Yu(Guangzhou Medical University), Song-pei Li(State Key Laboratory of Respiratory Disease), Jijun Fu(Guangdong Pharmaceutical University), Xueping Lei(State Key Laboratory of Respiratory Disease), Ao Shen(Sun Yat-sen University), Lin Tan(State Key Laboratory of Respiratory Disease), Yu Zhang(Wannan Medical College), Zhijun Chen(Guangzhou Medical University), Yuyan Qin(State Key Laboratory of Respiratory Disease), Lingmin Zhang(Tongji University), Aiping Qin(Guangxi Medical University), Wenyan Xu(State Key Laboratory of Respiratory Disease), Jionghua Huang(Second Affiliated Hospital of Guangzhou Medical University), Huiyu Cen(State Key Laboratory of Respiratory Disease)
Acta Pharmacologica Sinica
April 6, 2022
Cited by 30


Related Papers